Bian Zong-Mei, Elner Susan G, Elner Victor M
Department of Ophthalmology, University of Michigan, Ann Arbor, Michigan 48105, USA.
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2738-46. doi: 10.1167/iovs.06-1023.
The purpose of the present study was to investigate the effects of thrombin and thrombin in combination with other proangiogenic factors on VEGF expression in hRPE cells.
hRPE cells were stimulated with thrombin TNF-alpha, monocytes, and TGF-beta2. After stimulation, conditioned medium and lysed cells were subjected to ELISA, Western blot analysis, immunocytochemistry, and RT-PCR analyses. Inhibitors specific for various signal transduction pathways were used to determine the signaling pathways involved.
Treatment of RPE cells with thrombin resulted in dose- and time-dependent increases in VEGF mRNA levels and protein production. hRPE VEGF expression is predominantly protease-activated receptor (PAR)-1 dependent. Approximately 80% of thrombin-induced VEGF secretion was abrogated by inhibitors of MAPK/ERK kinase (MEK), p38, c-Jun NH2-terminal kinase (JNK), protein tyrosine kinase (PTK), phosphatidylinositol 3-kinase (PI3K), protein kinase C (PKC), nuclear factor-kappaB (NF-kappaB), and reactive oxygen species (ROS). Analyses of VEGF protein production and mRNA synthesis revealed that VEGF induction by thrombin plus TNF-alpha or coculture with monocytes was additive, whereas that by co-incubation with TGF-beta2 was synergistic. The costimulated VEGF production by TGF-beta2 plus thrombin was an average of three times higher than the sum of that induced by each agent alone. Furthermore, BAPTA [bis-(o-aminophenoxy)ethane-N,N',N'-tetraacetic acid], a calcium chelator, blocked the VEGF secretion induced by thrombin and thrombin plus TGF-beta2 by 65% and 20%, respectively, but had no effect on that induced by TGF-beta2 alone.
Thrombin alone and in combination with TNF-alpha, monocytes, and TGF-beta2 potently stimulated VEGF expression in hRPE cells via multiple signaling pathways. The thrombin-induced calcium mobilization may play an important permissive role in maximizing TGF-beta2-induced VEGF expression in RPE cells.
本研究旨在探讨凝血酶以及凝血酶与其他促血管生成因子联合作用对人视网膜色素上皮(hRPE)细胞中血管内皮生长因子(VEGF)表达的影响。
用凝血酶、肿瘤坏死因子-α(TNF-α)、单核细胞和转化生长因子-β2(TGF-β2)刺激hRPE细胞。刺激后,对条件培养基和裂解细胞进行酶联免疫吸附测定(ELISA)、蛋白质印迹分析、免疫细胞化学分析和逆转录-聚合酶链反应(RT-PCR)分析。使用针对各种信号转导途径的特异性抑制剂来确定其中涉及的信号通路。
用凝血酶处理RPE细胞导致VEGF mRNA水平和蛋白产生呈剂量和时间依赖性增加。hRPE细胞的VEGF表达主要依赖蛋白酶激活受体(PAR)-1。丝裂原活化蛋白激酶/细胞外信号调节激酶激酶(MEK)、p38、c-Jun氨基末端激酶(JNK)、蛋白酪氨酸激酶(PTK)、磷脂酰肌醇3-激酶(PI3K)、蛋白激酶C(PKC)、核因子-κB(NF-κB)和活性氧(ROS)的抑制剂可消除约80%的凝血酶诱导的VEGF分泌。对VEGF蛋白产生和mRNA合成的分析表明,凝血酶加TNF-α或与单核细胞共培养诱导的VEGF是相加的,而与TGF-β2共同孵育诱导的VEGF是协同的。TGF-β2加凝血酶共同刺激产生的VEGF平均比单独每种试剂诱导产生的VEGF之和高3倍。此外,钙螯合剂双(邻氨基苯氧基)乙烷-N,N',N'-四乙酸(BAPTA)分别使凝血酶和凝血酶加TGF-β2诱导的VEGF分泌减少65%和20%,但对单独TGF-β2诱导的VEGF分泌无影响。
单独的凝血酶以及与TNF-α、单核细胞和TGF-β2联合可通过多种信号通路有效刺激hRPE细胞中VEGF的表达。凝血酶诱导的钙动员可能在最大化TGF-β2诱导的RPE细胞中VEGF表达方面发挥重要的允许作用。